Literature DB >> 126875

Peripheral, ovarian, and adrenal vein steroids in hirsute women: acute effects of human chorionic gonadotropin and adrenocorticotrophic hormone.

C R Parker, D W Bruneteau, R B Greenblatt, V B Mahesh.   

Abstract

In an attempt to localize the source of excessive andogens in hirsute women, various steroids were determined in peripheral blood, left ovarian venous blood, and left adrenal venous blood, using radioimmunoassay techniques developed in our laboratory. Peripheral serum levels of dehydroepiandrosterone, androstenedione, 5alpha-dihydrotestosterone, testosterone, progesterone, and 17 alpha-hydroxyprogesterone were elevated in several hirsute patients, compared with those of a group of normal, cycling women of the same age. There was direct evidence to show that the ovaries and/or adrenals were secreting androgens in these hirsute patients. Saline infusion brought about minor changes in peripheral and left ovarian vein steroid levels; however, episodic fluctuations occurred in the adrenal vein samples. Adrenocorticotrophic hormone infusion brought about dramatic increases in adrenal vein steroid concentrations, while ovarian vein concentrations were unaffected, compared with peripheral steroid levels. Human chorionic gonadotropin (HCG) infusion brought about increases in left ovarian vein steroids in some patients; however, those patients with corpus luteum on the right ovary or under chronic ovarian suppression did not respond to HCG. HCG was ineffective in altering adrenal steroid secretion. It was concluded that selective venous cannulation may be of some use when the ovary is the site of excessive androgen secretion. However, care must be taken in interpreting results when a corpus luteum is present in the contralateral ovary. Interpretation is difficult when the adrenal is suspect, because of the pulsatile nature of adrenal secretion or the possibility of stress-induced secretion.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 126875

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  8 in total

1.  Type 5 17beta-hydroxysteroid dehydrogenase (AKR1C3) contributes to testosterone production in the adrenal reticularis.

Authors:  Yasuhiro Nakamura; Peter J Hornsby; Peter Casson; Ryo Morimoto; Fumitoshi Satoh; Yewei Xing; Michael R Kennedy; Hironobu Sasano; William E Rainey
Journal:  J Clin Endocrinol Metab       Date:  2009-03-31       Impact factor: 5.958

Review 2.  Hirsutism and virilisation.

Authors:  J Ginsburg; M C White
Journal:  Br Med J       Date:  1980-02-09

Review 3.  Adrenal androgens and androgen precursors-definition, synthesis, regulation and physiologic actions.

Authors:  Adina Turcu; Joshua M Smith; Richard Auchus; William E Rainey
Journal:  Compr Physiol       Date:  2014-10       Impact factor: 9.090

Review 4.  Hirsutism, virilism, polycystic ovarian disease, and the steroid-gonadotropin-feedback system: a career retrospective.

Authors:  Virendra B Mahesh
Journal:  Am J Physiol Endocrinol Metab       Date:  2011-10-25       Impact factor: 4.310

Review 5.  Steroid biomarkers in human adrenal disease.

Authors:  Juilee Rege; Adina F Turcu; Tobias Else; Richard J Auchus; William E Rainey
Journal:  J Steroid Biochem Mol Biol       Date:  2019-01-29       Impact factor: 4.292

6.  Androstenedione, 17 beta-estradiol and progesterone plasma levels in gonadotropins induction of ovulation.

Authors:  P Scirpa; D Mango; A Montemurro; F Battaglia; L Cantafio
Journal:  J Endocrinol Invest       Date:  1984-08       Impact factor: 4.256

Review 7.  Selective venous sampling for androgen-producing ovarian pathology.

Authors:  Eric D Levens; Brian W Whitcomb; John M Csokmay; Lynnette K Nieman
Journal:  Clin Endocrinol (Oxf)       Date:  2008-08-21       Impact factor: 3.478

Review 8.  Gonadotropin-Releasing Hormone Analogue Stimulation Test Versus Venous Sampling in Postmenopausal Hyperandrogenism.

Authors:  Eng-Loon Tng; Jeanne May May Tan
Journal:  J Endocr Soc       Date:  2020-11-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.